Phase 4 Asthma Trial, Recruiting NCT07402707 Sponsor: Sheffield Children's NHS Foundation Trust Condition: Asthma
Back to Asthma

Phase 4 Asthma Trial, Recruiting

NCT07402707
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between 4 and 15 years old (inclusive) who come to the emergency department with an asthma attack, where treatment guidelines recommend oral steroids as part of their care.
  • Children whose parents or carers speak Slovakian, Arabic, or Urdu (rather than English) may also be eligible, as interpreter services and information materials are available in those languages.

Who may not be able to join:

  • Children who have already been given oral or intravenous (IV) steroids within the last 2 weeks.
  • Children who have a known allergy or sensitivity to the study medication.
  • Children who currently have stridor (a high-pitched, noisy breathing sound distinct from asthma symptoms).
  • Children who are experiencing their very first episode of wheezing and have not previously been diagnosed with asthma.
  • Children who have been identified as having particularly difficult-to-manage asthma and typically need longer courses of steroids as part of their standard treatment.
  • Children who are having a life-threatening asthma episode.
  • Children who have another medical condition that requires them to take steroids when they are unwell.
  • Children who are currently taking part in another research study, or who have recently participated in one before being considered for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Judith Gilchrist, Sheffield Children's NHS Foundation Trust

Phone: 0114 3053136

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Sheffield Children's NHS Foundation Trust
Registry
ClinicalTrials.gov
Start date
23 February 2026
Est. completion
31 August 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Participant recruitment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov